Sectoral Scope

13. Waste handling and disposal

Mitigation
Outcome Label
Eligibility

Reduction

Status

Active since 04 September 2023

CDM methodology AMS-III.BA. Recovery and recycling of materials from E-waste (opens on external site) is applicable to project activities that collect and recycle E-waste in dedicated facilities with the aim of recovering materials such as ferrous metals, nonferrous metals, and plastics. E-waste contains rare and precious metals that require specific technologies to extract and refine them. These materials are recovered and processed into secondary materials, thus displacing the production of virgin materials, resulting in energy savings and reduced greenhouse gas emissions.

This methodology revision integrates a discount factor to account for uncertainty related to the displacement of production of virgin materials caused by the project activity.

Projects must apply VMR0008 in conjunction with AMS-III.BA. The CDM methodology AMS-III.BA. is excluded from the VCS Program for being used as a standalone methodology.

Please note: 

  • Projects listed before 4 September 2023 have a grace period until 4 March 2024 to complete validation using AMS-III.BA.
  • Effective 4 September 2023, AMS-III.BA. is excluded as a standalone methodology for new projects. New projects must use VMR0008 in conjunction with AMS-III.BA. 

Development History

VMR0008 Revision to AMS-III.BA.: Recovery and Recycling of Materials from E-waste
Status: Active since 4 September 2023
Grace Period: Projects listed before 4 September 2023 have a grace period until 4 March 2024 to complete validation using AMS-II.BA.
Developer: Verra developed this minor revision as a result of the August 2023 VCS Program Updates which introduces an upstream displacement discount factor.
Dates of Public Consultation: 13 July 2022 to 11 September 2022 (Public Consultation on Proposed Updates to the VCS Program)
Summary of Public Consultation: Summary of Public Comments: July 2022 VCS Program Update Consultation (PDF)
VVB Assessment Report: N/A